Company Snapshot: CNMD  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


CONMED Corporation Files Registration Statement for Common Stock Offering

    UTICA, N.Y., April 30 /PRNewswire-FirstCall/ --
CONMED Corporation (Nasdaq: CNMD) announced today that it filed a registration
statement with the Securities and Exchange Commission in connection with a
primary offering by the Company of 3,000,000 shares of its common stock.
    Salomon Smith Barney Inc. and UBS Warburg LLC are acting as managing
underwriters of the offering.
    CONMED is a medical technology company specializing in instruments,
implants, and video equipment for arthroscopic sports medicine, and powered
surgical instruments, such as drills and saws, for orthopedic, ENT,
neuro-surgery, and other surgical specialties.  The Company is also a leading
developer, manufacturer and supplier of advanced surgical devices, including
radio frequency, or RF, electrosurgery systems used routinely to cut and
cauterize tissue in nearly all types of surgical procedures worldwide, and
endoscopy products such as trocars, clip appliers, scissors, and surgical
staplers.  The Company also manufactures and sells a full line of ECG
electrodes for heart monitoring and other patient care products.
Headquartered in Utica, New York, the Company's 2,500 employees distribute its
products worldwide from eight manufacturing locations.
    A registration statement relating to the common stock has been filed with
the Securities and Exchange Commission but has not yet become effective.  The
common stock may not be sold nor may offers to buy be accepted prior to the
time the registration statement becomes effective.  This press release shall
not constitute an offer to sell or the solicitation of an offer to buy nor
shall there be any sale of these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.



SOURCE CONMED Corporation




Back to Topback to top

Related links:
  • http://www.conmed.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/201850.html
    CONTACT:
    Robert Shallish of CONMED Corporation, Chief
    Financial Officer, +1-315-624-3206; Investors - Theresa Vogt or
    Lanie Fladell, or Media - Dan Budwick, +1-212-850-5600, all of
    Morgen-Walke Associates, for CONMED Corporation